17-41084559-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033061.4(KRTAP4-7):c.353G>A(p.Cys118Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,571,572 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033061.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP4-7 | NM_033061.4 | c.353G>A | p.Cys118Tyr | missense_variant | 1/1 | ENST00000391417.6 | NP_149050.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP4-7 | ENST00000391417.6 | c.353G>A | p.Cys118Tyr | missense_variant | 1/1 | NM_033061.4 | ENSP00000375236 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000214 AC: 3AN: 140282Hom.: 0 Cov.: 22
GnomAD3 exomes AF: 0.000108 AC: 22AN: 203230Hom.: 2 AF XY: 0.000111 AC XY: 12AN XY: 108420
GnomAD4 exome AF: 0.0000182 AC: 26AN: 1431196Hom.: 3 Cov.: 37 AF XY: 0.0000169 AC XY: 12AN XY: 708806
GnomAD4 genome AF: 0.0000214 AC: 3AN: 140376Hom.: 0 Cov.: 22 AF XY: 0.0000147 AC XY: 1AN XY: 67984
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 21, 2024 | The c.353G>A (p.C118Y) alteration is located in exon 2 (coding exon 2) of the KRTAP4-7 gene. This alteration results from a G to A substitution at nucleotide position 353, causing the cysteine (C) at amino acid position 118 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at